These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical significance of serum CA 125 values in patients with gastric cancers--especially correlation with peritonitis carcinomatosa]. Takahashi Y; Suga T; Mai M Gan To Kagaku Ryoho; 1992 Jul; 19(7):975-9. PubMed ID: 1626954 [TBL] [Abstract][Full Text] [Related]
4. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer]. Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of positive cases with peritoneal lavage cytology in gastric cancer]. Yamamoto M; Mashino K; Shibahara K; Oki E; Kakeji Y; Baba H; Maehara Y Gan To Kagaku Ryoho; 2005 Oct; 32(10):1389-92. PubMed ID: 16227735 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of T antigen expression in patients with gastric carcinoma. Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672 [TBL] [Abstract][Full Text] [Related]
7. [Peritoneal lavage diagnosis with TRC (transcription reverse transcription concerted reaction) system for prediction of peritoneal recurrence in gastric cancer]. Hanada H; Fujiwara Y; Sohma I; Nakamura Y; Takeoka K; Iwatani Y; Hidaka Y Rinsho Byori; 2007 Nov; 55(11):1002-7. PubMed ID: 18154031 [TBL] [Abstract][Full Text] [Related]
8. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9]. Takahashi Y; Mai M Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402 [TBL] [Abstract][Full Text] [Related]
9. [Utility of dopa decarboxylase as a novel marker for the detection of peritoneal micro-metastases of gastric cancer with realtime RT-PCR]. Sakakura C; Takemura M; Miyagawa K; Fukuda K; Shimomura K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Ueda Y; Fujiyama J; Sonoyama T; Okazaki Y; Hayashizaki Y; Hagiwara A; Yamagishi H Gan To Kagaku Ryoho; 2004 Oct; 31(11):1906-8. PubMed ID: 15553755 [TBL] [Abstract][Full Text] [Related]
10. Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer. Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Miyagi Y; Morinaga S; Noguchi Y; Yamamoto Y Hepatogastroenterology; 2006; 53(72):964-7. PubMed ID: 17153464 [TBL] [Abstract][Full Text] [Related]
11. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination]. Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy of intra-peritoneal and intra-venous injection of monoclonal antibody A7-NCS conjugates against peritoneal dissemination of the gastric cancer]. Kuriu Y; Otsuji E; Okamoto K; Ichikawa D; Fujiwara H; Ochiai T; Sakakura C; Ueda Y; Sonoyama T; Hagiwara A; Yamagishi H Gan To Kagaku Ryoho; 2004 Oct; 31(11):1842-3. PubMed ID: 15553733 [TBL] [Abstract][Full Text] [Related]
15. [The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer]. Hirono Y; Fujimoto D; Nagano H; Murakami M; Katayama K; Yamaguchi A Gan To Kagaku Ryoho; 2008 Jun; 35(6):891-5. PubMed ID: 18633215 [TBL] [Abstract][Full Text] [Related]
16. [Related factors and prognosis of hepatic metastasis and peritoneal dissemination in gastric cancer]. Wang Z; Zhan WH; He YL; Cai SR; Peng JS; Chen CQ; Ma JP; Zheng ZQ Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):287-90. PubMed ID: 16886104 [TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer]. Fushida S; Fujita H; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T Gan To Kagaku Ryoho; 2005 Oct; 32(11):1691-4. PubMed ID: 16315911 [TBL] [Abstract][Full Text] [Related]
18. [Significance of the serum levels of Ca 19-9 and CA 50 in gastric cancer]. Loizate Totorikaguena A; Lamiquiz Vallejo A; Domínguez Merru-Urrutia MJ Rev Esp Enferm Apar Dig; 1987 Nov; 72(5 Pt 2):644-5. PubMed ID: 2452465 [No Abstract] [Full Text] [Related]
19. [A case of gastric cancer with peritoneal dissemination which has been alive more than three years responding to intraperitoneal chemotherapy]. Asami S; Idani H; Kubo S; Sasaki H; Kurose Y; Nojima H; Yoshioka T; Muro M; Kumano K; Hirata M; Yamashita T; Kin H; Takakura N Gan To Kagaku Ryoho; 2009 Nov; 36(12):2287-9. PubMed ID: 20037398 [TBL] [Abstract][Full Text] [Related]
20. [Screening of novel biomarkers for the detection of intraperitoneally disseminated cancer cells using human cDNA microarray]. Sakakura C; Simomura K; Shuichi K; Nakase Y; Fukuda K; Takagi T; Hagiwara A; Ichikawa Y; Nishizuka I; Ishikawa T; Okazaki Y; Yamagishi H Gan To Kagaku Ryoho; 2002 Nov; 29(12):2271-4. PubMed ID: 12484052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]